標(biāo)題: Titlebook: Malarial Drug Delivery Systems; Advances in Treatmen Ranjita Shegokar,Yashwant Pathak Book 2023 The Editor(s) (if applicable) and The Autho [打印本頁(yè)] 作者: 乳缽 時(shí)間: 2025-3-21 18:45
書(shū)目名稱(chēng)Malarial Drug Delivery Systems影響因子(影響力)
書(shū)目名稱(chēng)Malarial Drug Delivery Systems影響因子(影響力)學(xué)科排名
書(shū)目名稱(chēng)Malarial Drug Delivery Systems網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱(chēng)Malarial Drug Delivery Systems網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱(chēng)Malarial Drug Delivery Systems被引頻次
書(shū)目名稱(chēng)Malarial Drug Delivery Systems被引頻次學(xué)科排名
書(shū)目名稱(chēng)Malarial Drug Delivery Systems年度引用
書(shū)目名稱(chēng)Malarial Drug Delivery Systems年度引用學(xué)科排名
書(shū)目名稱(chēng)Malarial Drug Delivery Systems讀者反饋
書(shū)目名稱(chēng)Malarial Drug Delivery Systems讀者反饋學(xué)科排名
作者: deceive 時(shí)間: 2025-3-21 22:52
Chirag A. Patel,Sonal Pande,Priya Shukla,Ketan Ranch,Moawia M. Al-Tabakha,Sai H. S. Boddu reduce hazard or vulnerability, with a major attention to low impact solutions, possibly recovering local traditional techniques. Special attention has been posed to the Hiram Bingham Carretera, the unique way to access the site and where important debris flows have been identified.作者: 加強(qiáng)防衛(wèi) 時(shí)間: 2025-3-22 02:42
Dita Maria Virginia,Ranjita Shegokar,Yashwant Pathak reduce hazard or vulnerability, with a major attention to low impact solutions, possibly recovering local traditional techniques. Special attention has been posed to the Hiram Bingham Carretera, the unique way to access the site and where important debris flows have been identified.作者: defendant 時(shí)間: 2025-3-22 06:34
Himanshu Paliwal,Bhupendra G. Prajapati,Akshay Parihar,Geeta K. Patel,Prakash Kendre,Biswajit Basu,J reduce hazard or vulnerability, with a major attention to low impact solutions, possibly recovering local traditional techniques. Special attention has been posed to the Hiram Bingham Carretera, the unique way to access the site and where important debris flows have been identified.作者: Pulmonary-Veins 時(shí)間: 2025-3-22 12:09
Geeta K. Patel,Bhupendra Prajapati,Yashawant Pathakof hers at his AG Gallery in June of that year, but Ono thought it would be wrong to make it into a movement.. The first mention of Fluxus in print was in a notice, written in Lithuanian and designed by Maciunas, advertising a lecture on new music and old instruments.. The invitations sent out by th作者: TEM 時(shí)間: 2025-3-22 15:18 作者: 后天習(xí)得 時(shí)間: 2025-3-22 21:08
Global Health and Malaria: Past and Present, stringent drug regulations could prove beneficial in decreasing the presence of antibiotic resistance malaria against these counterfeit markets. The Middle East and Southern Asia have made great progress toward the elimination of malaria. It is important to note that these regions are also the leas作者: BUCK 時(shí)間: 2025-3-22 22:21 作者: 莎草 時(shí)間: 2025-3-23 04:43
Antimalarial Drug Resistance: Trends, Mechanisms, and Strategies to Combat Antimalarial Resistance,are crucial for making predictions on the onset and spread of resistance to existing antimalarial drugs and recently introduced molecules. Furthermore, understanding the mechanism of resistance and finding particular genetic loci linked to this phenotype are critical for antimalarial resistance surv作者: GENRE 時(shí)間: 2025-3-23 07:25 作者: 怕失去錢(qián) 時(shí)間: 2025-3-23 12:30
Polymeric Nanoparticles in Malaria,about the type of polymers used, preparation, and significant outcomes of some of the recent investigations. The last section of the chapter covered the polymeric nanoparticles containing a combination of antimalarial drugs.作者: acheon 時(shí)間: 2025-3-23 17:26
Solid Lipid Nanoparticles in Malaria,r; each of the sections focus upon one antimalarial, and the significant findings of researches are included in the content and tables. Lipid nanocarriers containing artesunate and a combination of artemether and lumefantrine are reported to be effective treatment options for severe and complicated 作者: 欄桿 時(shí)間: 2025-3-23 19:16
Potential of Micro-/Nanoemulsions as a Delivery Carrier to Treat Malaria,s/vehicles such as oils, surfactant, nanoemulsions, SNEDDS, NLC, SLNs, solid dispersions, nanolipid formulations, liposomes, etc. Nanoemulsifying systems have shown substantial promising results in successful delivery of such drugs in terms of enhancing bioavailability of poorly soluble compounds as作者: 油膏 時(shí)間: 2025-3-24 01:16
Nanosuspensions in Treatment of Malaria,c. The chapter?also gives an insight into the method of preparation, formulation, and evaluation parameters for nanosuspension. It also addresses nanosuspensions formulated for different antimalarial drugs with their advantages over conventional formulation. The present chapter also gives details on作者: RLS898 時(shí)間: 2025-3-24 06:21 作者: 我不怕?tīng)奚?nbsp; 時(shí)間: 2025-3-24 10:16 作者: ORBIT 時(shí)間: 2025-3-24 14:36
Clinical Trials in Malaria,lobal elimination of the disease. Currently, several malaria vaccine candidates have been developed and are being evaluated in several African research institutions. Among these RTS,S is leading the study for which the most significant Phase 3 trial of malaria vaccine trial involving 16,000 children作者: Aerophagia 時(shí)間: 2025-3-24 18:23
Potential of Herbal Drug Delivery in Treating Malaria,emisinin and quinine derivatives are the best examples. Moreover, nature continues to provide us with an abundance of secondary metabolites that remain unexplored to date. This chapter has profiled many of the plants used around the world for the treatment of malaria, their mechanism of action, and 作者: NIL 時(shí)間: 2025-3-24 23:03
Exploration on Metal Nanoparticles for Treatment of Malaria,ld potentially treat malaria. Metallic nanoparticles are effective against the malaria parasite . and the vector female . mosquito. Metallic nanoparticles are thought to offer a potential answer for malaria control. This chapter focuses on the current scenario of conventional antimalarial medication作者: 消散 時(shí)間: 2025-3-25 01:04
-vitro and in-vivo. Audience from wide range group like from researchers to regulatory bodies can benefit from the compiled information to find out patient needs and addresses a much-needed update to the existing malaria drug delivery research.978-3-031-16506-1978-3-031-15848-3作者: Limousine 時(shí)間: 2025-3-25 03:30
chaftlich hochexplosive Perspektiven sich mit der KI verbinden und welche ethischen und philosophischen Fragestellungen sich daraus ergeben.978-3-658-31863-5Series ISSN 2730-7425 Series E-ISSN 2730-7433 作者: 無(wú)動(dòng)于衷 時(shí)間: 2025-3-25 11:22 作者: confide 時(shí)間: 2025-3-25 15:09 作者: aggrieve 時(shí)間: 2025-3-25 18:53
Chaudhary Sunita,Khodakiya Akruti,Chaudhary Ankit,Jayvadan K. Patel作者: 蝕刻術(shù) 時(shí)間: 2025-3-25 21:10 作者: 閹割 時(shí)間: 2025-3-26 00:43 作者: 平 時(shí)間: 2025-3-26 05:17
Kartik Hariharan,Harshit Barot,Jahanavi Patel,Mohit Shah,Tejal Mehta作者: 漂浮 時(shí)間: 2025-3-26 11:07
Dasharath Patel,Sanjay Chauhan,Vikash Tiwari,Devashri Vadiya,Jayvadan K. Patel作者: Aggressive 時(shí)間: 2025-3-26 13:13
Aparoop Das,Kalyani Pathak,Manash Pratim Pathak,Riya Saikia,Urvashee Gogoi,Niyati S. Acharya作者: happiness 時(shí)間: 2025-3-26 18:48
Ranjita Shegokar,Yashwant PathakCrucial update to new malaria drugs and drug delivery possibilities.Focuses on nanoparticle drug delivery as the newest weapon in the arsenal to treat malaria.Includes an overview of malaria today and作者: 充氣女 時(shí)間: 2025-3-26 22:03 作者: Thrombolysis 時(shí)間: 2025-3-27 04:21 作者: RENIN 時(shí)間: 2025-3-27 07:53
978-3-031-16506-1The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl作者: SEMI 時(shí)間: 2025-3-27 11:46 作者: Perineum 時(shí)間: 2025-3-27 15:37 作者: synovial-joint 時(shí)間: 2025-3-27 20:07 作者: 脖子 時(shí)間: 2025-3-27 23:03
,Malaria – Current Treatment Options, are recommended as first-line therapy for uncomplicated . and second-line therapy for non-.. There are five ACTs approved by WHO: artesunate-amodiaquine, artemether-lumefantrine (AL), artesunate-mefloquine, artesunate-sulfadoxine-pyrimethamine, and dihydroartemisinin-piperaquine (DHA?+?PPQ). Quinin作者: hieroglyphic 時(shí)間: 2025-3-28 04:54
Polymeric Nanoparticles in Malaria,ance, poor water solubility, low bioavailability, toxicity due to drugs, etc. are some of those crucial issues. Further, the lack of innovations in terms of the discovery of antiparasitic agents in the last decade has generated the need for improving the available therapies by modifying their delive作者: 出汗 時(shí)間: 2025-3-28 09:51
Solid Lipid Nanoparticles in Malaria,ldwide. The life-threatening outcomes of the disease can be prevented in early diagnosis and therapeutic intervention. The major reason leading to the rise in the mortality rate is the increase in the parasitic population exhibiting drug resistance. To overcome this problem, research has been shifte作者: foreign 時(shí)間: 2025-3-28 11:31 作者: Allowance 時(shí)間: 2025-3-28 15:55 作者: amputation 時(shí)間: 2025-3-28 21:46 作者: 種子 時(shí)間: 2025-3-28 22:55
Nanosuspensions in Treatment of Malaria,fection. Artemisinin-based combination therapy for 3?days is recommended by WHO because it quickly reduces the number of parasites from the blood. It is utilized as the first- and second-line treatment of infection of . and . Development of drug resistance and nonspecific targeting to intracellular 作者: 侵略者 時(shí)間: 2025-3-29 05:26
Alginate-Gelatin Nanoparticles in Malaria,conventional chemotherapy. The chapter provides insight into employing nanocarriers as drug delivery methods to increase drug protection against extracellular degradation, improve target selectivity, and minimize the incidence of side effects. It provides in-depth discussion on various methods for t作者: CUMB 時(shí)間: 2025-3-29 08:44 作者: 能得到 時(shí)間: 2025-3-29 14:56
Surface-Modified Drug Delivery Systems in Malaria,aria is undoubtedly one of the major serious medical issues across the globe. Conventional treatment has a number of disadvantages, including poor physiochemical properties such as low water solubility, low bioavailability, and chemical instability. As a result, a large dosage is needed to attain ef作者: 表否定 時(shí)間: 2025-3-29 15:41 作者: condescend 時(shí)間: 2025-3-29 22:02
Potential of Herbal Drug Delivery in Treating Malaria, world. No vaccination against malaria has been developed yet, owing to the parasite’s constant alteration of the metabolic pathways’ interaction over its life cycle, leading to high mortality rate. Treatment of malaria has faced set back due to the growing problem of drug resistance by the malarial作者: META 時(shí)間: 2025-3-30 02:48
Exploration on Metal Nanoparticles for Treatment of Malaria,or the deaths of an estimated 17?million people each year. These diseases have a more significant impact in developing countries. The most vulnerable are people with weakened immune systems and youngsters. Bacteria, viruses, and protozoa can all cause infectious diseases. Malaria is one of the most 作者: CHASM 時(shí)間: 2025-3-30 06:40 作者: BARGE 時(shí)間: 2025-3-30 10:38 作者: 根除 時(shí)間: 2025-3-30 12:51 作者: 螢火蟲(chóng) 時(shí)間: 2025-3-30 17:56 作者: 開(kāi)始沒(méi)有 時(shí)間: 2025-3-30 22:58 作者: flamboyant 時(shí)間: 2025-3-31 02:57 作者: 我要沮喪 時(shí)間: 2025-3-31 07:51
Geeta K. Patel,Bhupendra Prajapati,Yashawant Pathak critical interest in this avant-garde movement, whether from a scholarly or from an ideological point of view. In a certain way, the Fluxus project lives off these contradictions, which have crystallized in a variety of narratives about Fluxus.. That Fluxus was an international movement with region作者: 變化無(wú)常 時(shí)間: 2025-3-31 11:23 作者: GOAD 時(shí)間: 2025-3-31 17:22
Book 2023modalities?and how?the former is superior in?pharmacological performance when tested in in-vitro and in-vivo. Audience from wide range group like from researchers to regulatory bodies can benefit from the compiled information to find out patient needs and addresses a much-needed update to the existing malaria drug delivery research.作者: 細(xì)胞學(xué) 時(shí)間: 2025-3-31 19:21
